https://www.fda.gov/drugs/news-events-human-drugs/public-meeting-patient-focused-drug-development-vitiligo-03082021-03082021

On March 8, 2021, FDA is hosting a virtual public meeting on Patient-Focused Drug Development for Vitiligo. FDA is interested in hearing patients’ perspectives on the impact of vitiligo on daily life and patient views on treatment approaches.

• Health effects and daily impacts of their vitiligo
• Treatment goals
• Decision factors considered when seeking out or selecting a treatment

This website will be updated as meeting materials are developed.

Date:

March 8, 2021

Time:

10:00 a.m. - 2:30 p.m. EST